Athersys ATHX
$ 0.1
3.77%
Quarterly report 2023-Q3
added 11-16-2023
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Dr. Gil Van Bokkelen |
Employees in the company |
83 |
Shares |
224 M |
Market Cap[1] |
$ 22.4 M |
EBITDA (LTM) |
$ -43.1 M |
P/E (LTM) |
-0.04 |
P/S (LTM) |
- |
EPS (LTM) |
-2.35 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.